-
Mashup Score: 4Cancer of the Vulva - Cancer Stat Facts - 1 year(s) ago
Vulvar Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Cancer of the Vulva - Cancer Stat Facts - 1 year(s) ago
Vulvar Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
#VulvarCancer is a rare cancer that is most frequently diagnosed among women aged 65–74. Visit our Cancer Stat Facts sheet to learn more: https://t.co/75ThX2FKfh https://t.co/8hari039ZH
-
-
Mashup Score: 4Cancer of the Vulva - Cancer Stat Facts - 1 year(s) ago
Vulvar Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
#VulvarCancer is a rare cancer that is most frequently diagnosed among women aged 65–74. Visit our Cancer Stat Facts sheet to learn more: https://t.co/75ThX2FKfh https://t.co/8hari039ZH
-
-
Mashup Score: 1
Vulvar cancer is a rare gynecologic tumor treated with radiotherapy that affects the host immune system. Here, we provide new insight into systemic therapy-induced individual immunity of patients, re…
Source: onlinelibrary.wiley.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NOW ONLINE New study identified individual therapy-induced immune milieus of #VulvarCancer patients and linked high proportions of Th17 and Tc17 cells in the patients' blood after irradiation with reduced recurrence free survival 🔓OPEN ACCESS ➡️https://t.co/6RYfs4LCxg https://t.co/uUHr11xujC
-
-
Mashup Score: 0
By The ASCO Post Staff Posted: 3/30/2023 10:54:00 AM Last Updated: 3/30/2023 1:57:12 PM Researchers have found that concurrent treatment with gemcitabine as well as cisplatin and intensity-modulated radiation therapy may effectively increase the pathologic complete response rates in patients with locally…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
More on @NRGonc trial @GOG 279 at #SGOmtg! #Gemcitabine Plus #Cisplatin and #IMRT Produces Complete Responses in #vulvarcancer. From @ASCOPost #gyncsm #NRGatSGO #SGO2023 #clinicaltrial #oncology https://t.co/AIk3evaoQA
-
-
Mashup Score: 0Prevalence of HPV DNA and p16INK4a Positivity in Vulvar Cancer and Vulvar Intraepithelial Neoplasia - The ASCO Post - 2 year(s) ago
By Matthew Stenger Posted: 3/22/2023 10:30:00 AM Last Updated: 3/22/2023 9:41:18 AM In a global systematic review and meta-analysis reported in The Lancet Oncology, Li et al found a high prevalence of human papillomavirus (HPV) genotype 16 and HPV33 in vulvar cancer and vulvar intraepithelial neoplasia, as…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Prevalence of HPV DNA and p16INK4a Positivity in Vulvar Cancer and Vulvar Intraepithelial Neoplasia https://t.co/A0xYFt17wz #HPV #gyncsm #vulvarcancer
-
-
Mashup Score: 2Teresa’s Cancer Survivor Story | CDC - 2 year(s) ago
“I’d much rather be embarrassed and alive than modest and dead. Early detection is key.”; Teresa W., Vulvar Cancer Survivor
Source: www.cdc.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“I’d much rather be embarrassed and alive than modest and dead. Early detection is key.” Teresa shares her experience with #VulvarCancer. Read her story. https://t.co/dqrMmxKgvB @CDC_Cancer https://t.co/SpPKIiv45j
-
-
Mashup Score: 0Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001–2018 - 2 year(s) ago
We found evidence that HPV vaccinations likely contributed to a decrease in the incidences of vulvar carcinoma in situ and invasive vulvar carcinoma among 20- to 44-year-old women between 2001 and 2018. Our data add to the growing evidence that HPV vaccinations are reducing the incidence of HPV-related anogenital cancers.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the November Issue: #VulvarCancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001–2018, by Berenson et al. https://t.co/l6whqFaa31 @utmbhealth @UTHealthObGyn https://t.co/l7dmmhAW4K
-
-
Mashup Score: 0Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001–2018 - 2 year(s) ago
We found evidence that HPV vaccinations likely contributed to a decrease in the incidences of vulvar carcinoma in situ and invasive vulvar carcinoma among 20- to 44-year-old women between 2001 and 2018. Our data add to the growing evidence that HPV vaccinations are reducing the incidence of HPV-related anogenital cancers.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the November Issue: #VulvarCancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001–2018, by Berenson et al. https://t.co/fXHYPi8X0K @utmbhealth @UTHealthObGyn https://t.co/z7Zuh7vjJ3
-
-
Mashup Score: 0Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001–2018 - 3 year(s) ago
We found evidence that HPV vaccinations likely contributed to a decrease in the incidences of vulvar carcinoma in situ and invasive vulvar carcinoma among 20- to 44-year-old women between 2001 and 2018. Our data add to the growing evidence that HPV vaccinations are reducing the incidence of HPV-related anogenital cancers.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the November Issue— #VulvarCancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001–2018, by Berenson et al. https://t.co/9CnxbzpmvG @utmbhealth @UTHealthObGyn https://t.co/xQpiPMwMUt
-
#VulvarCancer is a rare cancer that is most frequently diagnosed among women aged 65–74. Visit our Cancer Stat Facts sheet to learn more: https://t.co/75ThX2FKfh https://t.co/8hari039ZH